Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,862 | 108,743 | 46,464 | 48,275 | 57,288 |
| Receivables | 70,020 | 86,177 | 72,984 | 93,142 | 97,070 |
| Other current assets | 89,049 | 75,730 | 393,522 | 351,768 | 395,967 |
| TOTAL | $221,811 | $280,288 | $520,819 | $499,579 | $557,108 |
| Non-Current Assets | |||||
| PPE Net | 1,978,826 | 2,035,342 | 1,820,735 | 1,889,266 | 1,882,452 |
| Investments And Advances | 463,251 | 479,276 | 495,488 | 472,790 | 460,235 |
| Intangibles | 0 | 19,514 | 0 | 20,319 | 20,722 |
| Other Non-Current Assets | 82,045 | 64,058 | 64,723 | 68,780 | 64,373 |
| TOTAL | $2,524,122 | $2,598,190 | $2,380,946 | $2,451,155 | $2,427,782 |
| Total Assets | $2,745,933 | $2,878,478 | $2,901,765 | $2,950,734 | $2,984,890 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 251,250 | 216,519 | 218,094 | 309,500 | 313,064 |
| Accounts payable and accrued liabilities | 7,913 | 13,524 | 29,671 | 64,870 | 84,035 |
| Accrued Expenses | 24,365 | 26,180 | 25,206 | 25,981 | 21,509 |
| Other current liabilities | 6,517 | N/A | 8,752 | N/A | N/A |
| TOTAL | $296,847 | $262,701 | $288,128 | $406,706 | $425,056 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,728,310 | 1,888,634 | 1,880,122 | 1,819,649 | 1,825,858 |
| Deferred Revenues | 6,802 | 6,478 | 6,405 | 6,355 | 6,448 |
| Other Non-Current Liabilities | 4,148 | 5,124 | 4,899 | 5,333 | 1,784 |
| TOTAL | $1,761,619 | $1,925,630 | $1,920,397 | $1,858,036 | $1,867,648 |
| Total Liabilities | $2,058,466 | $2,188,331 | $2,208,525 | $2,264,742 | $2,292,704 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,553 | 17,506 | 17,487 | 17,426 | 17,420 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 486,924 | 489,757 | 493,294 | 487,653 | 494,607 |
| Other shareholders' equity | 97,199 | 97,098 | 97,235 | 97,020 | 97,276 |
| TOTAL | $687,467 | $690,147 | $693,240 | $685,992 | $692,186 |
| Total Liabilities And Equity | $2,745,933 | $2,878,478 | $2,901,765 | $2,950,734 | $2,984,890 |